About
Peptidream Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 20 2026
PeptiDream Announces the Initiation of Phase 1 Clinical Trial by Its Collaboration Partner
Dec 18 2025
PeptiDream and Alnylam Announce Achievement of Key Milestone in siRNA Conjugate Discovery Collaboration Demonstrating Peptide-Ligand Mediated Targeted siRNA Delivery to Specific Extrahepatic Tissues
Dec 17 2025
PeptiDream Announces Promising Pre-Clinical Results of Proprietary Oral IL-17A and IL-17F Dual Inhibitor with Biologic-Like Efficacy for the Treatment of Psoriasis
Oct 15 2025
PeptiDream, PDRadiopharma and Curium Group Enroll First Patient to Registrational Clinical Trial of 64Cu-PSMA-I&T for Prostate Cancer in Japan
Recent Videos

1倍→5倍→10倍株|これから伸びる成長銘柄を徹底解説
Mar 29, 2026

リード・パトリック アメリカの実業家 ペプチドリーム株式会社の社長
Mar 08, 2026

ペプチドリーム:2025年12月期決算説明会動画(2026年2月16日開催、オリジナル音声)
Feb 24, 2026

PeptiDream Q4 2025 Earnings Call
Feb 18, 2026
Google Übersetzer